Key Trends Influencing the Growth of the Crohn's Disease Treatment Market in 2025: Innovating New Drugs To Transform The Crohn's Disease Treatment Landscape

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Crohn's Disease Treatment Market Through 2025?
There has been significant expansion in the size of the market for treatment of Crohn's disease in the last few years. It is anticipated to rise from $12.45 billion in 2024 to $13.1 billion in 2025, with a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this growth during the historic period include higher disease prevalence, improved diagnostic methods, the adoption of biological therapies, heightened patient awareness and education, as well as advancements in clinical research and development.

What's the Projected Size of the Global Crohn's Disease Treatment Market by 2029?
In the subsequent few years, the market size for Crohn's disease treatment is predicted to experience robust growth, with an expected worth of $17.34 billion in 2029, increasing at a compound annual growth rate (CAGR) of 7.3%. This expected growth during the forecast period can be associated with factors like personalized medicine practices, growth in the biologics market, updated treatment guidelines, a boost in healthcare expenditure, and joint research initiatives. Key trends forecasted in the same period involve the utilization of telemedicine for managing patients, investigations into immune modulation techniques, patient-focused care systems, and the incorporation of digital health solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

Top Growth Drivers in the Crohn's Disease Treatment Industry: What's Accelerating the Market?
The surge in inflammatory bowel disorders prevalence is anticipated to drive the Crohn's disease treatment market's expansion. Inflammatory bowel disorders are a set of chronic conditions marked by inflammation in the gastrointestinal tract. These disorders can trigger inflammation and damage anywhere within the digestive system, from the mouth to the anus. Crohn's disease treatment works by reducing intestinal inflammation, preventing symptom outbreaks, and maintaining remission. For example, as per the US-based National Center for Biotechnology Information's data from September 2023, the prevalence of Crohn's disease and ulcerative colitis has shown a similar increase. They projected inflammatory bowel disease at 825 cases per 100,000 people in 2023, divided between 410 for Crohn's disease and 414 for ulcerative colitis and IBD-u. Consequently, the escalating prevalence of these conditions is pushing the growth of the Crohn's disease treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp

What Are the Key Trends Driving Crohn's Disease Treatment Market Growth?
Leading companies in the crohn's disease treatment market are focusing on creating and gaining approval for new drugs, including biosimilar ustekinumab, to bolster treatment choices for patients and ultimately enhance patient prognosis and life quality. The term biosimilar ustekinumab refers to a biologic drug very similar to the original ustekinumab which is a monoclonal antibody utilized for the treatment of autoimmune diseases. Notably, in July 2024, Swiss-based Sandoz International GmbH introduced Pyzchiva (ustekinumab) across Europe, establishing it as the first ustekinumab biosimilar available in all strengths, notably including a 130 mg vial tailored for Crohn's disease. This drug is prescribed for adults and children over six for plaque psoriasis, psoriatic arthritis, and Crohn's disease. This has elevated Sandoz's immunology product offering while striving to expand access to cost-effective treatments for chronic inflammatory diseases.

What Are the Main Segments in the Crohn's Disease Treatment Market?
The crohn's disease treatment market covered in this report is segmented -

1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications

Subsegments:
1) By Antibiotics: Metronidazole, Ciprofloxacin, Other Antibiotics
2) By Amino Salicylates: Mesalamine, Sulfasalazine, Other Amino Salicylates
3) By Corticosteroids: Prednisone, Budesonide, Other Corticosteroids
4) By Immunomodulators: Azathioprine, Methotrexate, Mercaptopurine
5) By Other Drug Types: Biologics, Small Molecules, Other Treatments

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10852&type=smp

Which Top Companies are Driving Growth in the Crohn's Disease Treatment Market?
Major companies operating in the crohn's disease treatment market include AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Bristol-Myers Squibb Company, Galapagos NV, Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Arena Pharmaceuticals Inc.

Which Regions Will Dominate the Crohn's Disease Treatment Market Through 2029?
North America was the largest region in the global Crohn's disease treatment market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the Crohn's disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10852

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.